Report Overview
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
The global Imatinib Drug market size was estimated at USD 2781 million in 2023 and is projected to reach USD 3890.25 million by 2032, exhibiting a CAGR of 3.80% during the forecast period.
North America Imatinib Drug market size was estimated at USD 772.62 million in 2023, at a CAGR of 3.26% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Imatinib Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Imatinib Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Imatinib Drug market in any manner.
Global Imatinib Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
Market Segmentation (by Type)
Tablets
Capsules
Market Segmentation (by Application)
Chronic Myelogenous Leukemia
Gastrointestinal Stromal Tumors
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Imatinib Drug Market
� Overview of the regional outlook of the Imatinib Drug Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Imatinib Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Imatinib Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Imatinib Drug
1.2 Key Market Segments
1.2.1 Imatinib Drug Segment by Type
1.2.2 Imatinib Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Imatinib Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Imatinib Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Imatinib Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Imatinib Drug Market Competitive Landscape
3.1 Global Imatinib Drug Sales by Manufacturers (2019-2025)
3.2 Global Imatinib Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Imatinib Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Imatinib Drug Sales Sites, Area Served, Product Type
3.6 Imatinib Drug Market Competitive Situation and Trends
3.6.1 Imatinib Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Imatinib Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Imatinib Drug Industry Chain Analysis
4.1 Imatinib Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Imatinib Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Imatinib Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Imatinib Drug Sales Market Share by Type (2019-2025)
6.3 Global Imatinib Drug Market Size Market Share by Type (2019-2025)
6.4 Global Imatinib Drug Price by Type (2019-2025)
7 Imatinib Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Imatinib Drug Market Sales by Application (2019-2025)
7.3 Global Imatinib Drug Market Size (M USD) by Application (2019-2025)
7.4 Global Imatinib Drug Sales Growth Rate by Application (2019-2025)
8 Imatinib Drug Market Consumption by Region
8.1 Global Imatinib Drug Sales by Region
8.1.1 Global Imatinib Drug Sales by Region
8.1.2 Global Imatinib Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Imatinib Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Imatinib Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Imatinib Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Imatinib Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Imatinib Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Imatinib Drug Market Production by Region
9.1 Global Production of Imatinib Drug by Region (2019-2025)
9.2 Global Imatinib Drug Revenue Market Share by Region (2019-2025)
9.3 Global Imatinib Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Imatinib Drug Production
9.4.1 North America Imatinib Drug Production Growth Rate (2019-2025)
9.4.2 North America Imatinib Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Imatinib Drug Production
9.5.1 Europe Imatinib Drug Production Growth Rate (2019-2025)
9.5.2 Europe Imatinib Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Imatinib Drug Production (2019-2025)
9.6.1 Japan Imatinib Drug Production Growth Rate (2019-2025)
9.6.2 Japan Imatinib Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Imatinib Drug Production (2019-2025)
9.7.1 China Imatinib Drug Production Growth Rate (2019-2025)
9.7.2 China Imatinib Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Novartis
10.1.1 Novartis Imatinib Drug Basic Information
10.1.2 Novartis Imatinib Drug Product Overview
10.1.3 Novartis Imatinib Drug Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis Imatinib Drug SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Glenmark Pharmaceuticals Ltd.
10.2.1 Glenmark Pharmaceuticals Ltd. Imatinib Drug Basic Information
10.2.2 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Overview
10.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Market Performance
10.2.4 Glenmark Pharmaceuticals Ltd. Business Overview
10.2.5 Glenmark Pharmaceuticals Ltd. Imatinib Drug SWOT Analysis
10.2.6 Glenmark Pharmaceuticals Ltd. Recent Developments
10.3 Sun Pharmaceuticals
10.3.1 Sun Pharmaceuticals Imatinib Drug Basic Information
10.3.2 Sun Pharmaceuticals Imatinib Drug Product Overview
10.3.3 Sun Pharmaceuticals Imatinib Drug Product Market Performance
10.3.4 Sun Pharmaceuticals Imatinib Drug SWOT Analysis
10.3.5 Sun Pharmaceuticals Business Overview
10.3.6 Sun Pharmaceuticals Recent Developments
10.4 Actavis Generics
10.4.1 Actavis Generics Imatinib Drug Basic Information
10.4.2 Actavis Generics Imatinib Drug Product Overview
10.4.3 Actavis Generics Imatinib Drug Product Market Performance
10.4.4 Actavis Generics Business Overview
10.4.5 Actavis Generics Recent Developments
10.5 Dr. Reddy's Laboratories
10.5.1 Dr. Reddy's Laboratories Imatinib Drug Basic Information
10.5.2 Dr. Reddy's Laboratories Imatinib Drug Product Overview
10.5.3 Dr. Reddy's Laboratories Imatinib Drug Product Market Performance
10.5.4 Dr. Reddy's Laboratories Business Overview
10.5.5 Dr. Reddy's Laboratories Recent Developments
10.6 Teva Pharmaceutical Industries Ltd.
10.6.1 Teva Pharmaceutical Industries Ltd. Imatinib Drug Basic Information
10.6.2 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Overview
10.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Market Performance
10.6.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.7 Sanofi S.A.
10.7.1 Sanofi S.A. Imatinib Drug Basic Information
10.7.2 Sanofi S.A. Imatinib Drug Product Overview
10.7.3 Sanofi S.A. Imatinib Drug Product Market Performance
10.7.4 Sanofi S.A. Business Overview
10.7.5 Sanofi S.A. Recent Developments
10.8 Cipla Inc.
10.8.1 Cipla Inc. Imatinib Drug Basic Information
10.8.2 Cipla Inc. Imatinib Drug Product Overview
10.8.3 Cipla Inc. Imatinib Drug Product Market Performance
10.8.4 Cipla Inc. Business Overview
10.8.5 Cipla Inc. Recent Developments
10.9 Apotex Inc.
10.9.1 Apotex Inc. Imatinib Drug Basic Information
10.9.2 Apotex Inc. Imatinib Drug Product Overview
10.9.3 Apotex Inc. Imatinib Drug Product Market Performance
10.9.4 Apotex Inc. Business Overview
10.9.5 Apotex Inc. Recent Developments
10.10 Mylan Pharms Inc.
10.10.1 Mylan Pharms Inc. Imatinib Drug Basic Information
10.10.2 Mylan Pharms Inc. Imatinib Drug Product Overview
10.10.3 Mylan Pharms Inc. Imatinib Drug Product Market Performance
10.10.4 Mylan Pharms Inc. Business Overview
10.10.5 Mylan Pharms Inc. Recent Developments
11 Imatinib Drug Market Forecast by Region
11.1 Global Imatinib Drug Market Size Forecast
11.2 Global Imatinib Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Imatinib Drug Market Size Forecast by Country
11.2.3 Asia Pacific Imatinib Drug Market Size Forecast by Region
11.2.4 South America Imatinib Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Imatinib Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Imatinib Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Imatinib Drug by Type (2025-2032)
12.1.2 Global Imatinib Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Imatinib Drug by Type (2025-2032)
12.2 Global Imatinib Drug Market Forecast by Application (2025-2032)
12.2.1 Global Imatinib Drug Sales (K MT) Forecast by Application
12.2.2 Global Imatinib Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Imatinib Drug Market Size Comparison by Region (M USD)
Table 5. Global Imatinib Drug Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Imatinib Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Imatinib Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Imatinib Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drug as of 2022)
Table 10. Global Market Imatinib Drug Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Imatinib Drug Sales Sites and Area Served
Table 12. Manufacturers Imatinib Drug Product Type
Table 13. Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Imatinib Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Imatinib Drug Market Challenges
Table 22. Global Imatinib Drug Sales by Type (K MT)
Table 23. Global Imatinib Drug Market Size by Type (M USD)
Table 24. Global Imatinib Drug Sales (K MT) by Type (2019-2025)
Table 25. Global Imatinib Drug Sales Market Share by Type (2019-2025)
Table 26. Global Imatinib Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global Imatinib Drug Market Size Share by Type (2019-2025)
Table 28. Global Imatinib Drug Price (USD/MT) by Type (2019-2025)
Table 29. Global Imatinib Drug Sales (K MT) by Application
Table 30. Global Imatinib Drug Market Size by Application
Table 31. Global Imatinib Drug Sales by Application (2019-2025) & (K MT)
Table 32. Global Imatinib Drug Sales Market Share by Application (2019-2025)
Table 33. Global Imatinib Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global Imatinib Drug Market Share by Application (2019-2025)
Table 35. Global Imatinib Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global Imatinib Drug Sales by Region (2019-2025) & (K MT)
Table 37. Global Imatinib Drug Sales Market Share by Region (2019-2025)
Table 38. North America Imatinib Drug Sales by Country (2019-2025) & (K MT)
Table 39. Europe Imatinib Drug Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Imatinib Drug Sales by Region (2019-2025) & (K MT)
Table 41. South America Imatinib Drug Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Imatinib Drug Sales by Region (2019-2025) & (K MT)
Table 43. Global Imatinib Drug Production (K MT) by Region (2019-2025)
Table 44. Global Imatinib Drug Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Imatinib Drug Revenue Market Share by Region (2019-2025)
Table 46. Global Imatinib Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Imatinib Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Imatinib Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Imatinib Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Imatinib Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Novartis Imatinib Drug Basic Information
Table 52. Novartis Imatinib Drug Product Overview
Table 53. Novartis Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Novartis Business Overview
Table 55. Novartis Imatinib Drug SWOT Analysis
Table 56. Novartis Recent Developments
Table 57. Glenmark Pharmaceuticals Ltd. Imatinib Drug Basic Information
Table 58. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Overview
Table 59. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Glenmark Pharmaceuticals Ltd. Business Overview
Table 61. Glenmark Pharmaceuticals Ltd. Imatinib Drug SWOT Analysis
Table 62. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 63. Sun Pharmaceuticals Imatinib Drug Basic Information
Table 64. Sun Pharmaceuticals Imatinib Drug Product Overview
Table 65. Sun Pharmaceuticals Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Sun Pharmaceuticals Imatinib Drug SWOT Analysis
Table 67. Sun Pharmaceuticals Business Overview
Table 68. Sun Pharmaceuticals Recent Developments
Table 69. Actavis Generics Imatinib Drug Basic Information
Table 70. Actavis Generics Imatinib Drug Product Overview
Table 71. Actavis Generics Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Actavis Generics Business Overview
Table 73. Actavis Generics Recent Developments
Table 74. Dr. Reddy's Laboratories Imatinib Drug Basic Information
Table 75. Dr. Reddy's Laboratories Imatinib Drug Product Overview
Table 76. Dr. Reddy's Laboratories Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Dr. Reddy's Laboratories Business Overview
Table 78. Dr. Reddy's Laboratories Recent Developments
Table 79. Teva Pharmaceutical Industries Ltd. Imatinib Drug Basic Information
Table 80. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Overview
Table 81. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Teva Pharmaceutical Industries Ltd. Business Overview
Table 83. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 84. Sanofi S.A. Imatinib Drug Basic Information
Table 85. Sanofi S.A. Imatinib Drug Product Overview
Table 86. Sanofi S.A. Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Sanofi S.A. Business Overview
Table 88. Sanofi S.A. Recent Developments
Table 89. Cipla Inc. Imatinib Drug Basic Information
Table 90. Cipla Inc. Imatinib Drug Product Overview
Table 91. Cipla Inc. Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Cipla Inc. Business Overview
Table 93. Cipla Inc. Recent Developments
Table 94. Apotex Inc. Imatinib Drug Basic Information
Table 95. Apotex Inc. Imatinib Drug Product Overview
Table 96. Apotex Inc. Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Apotex Inc. Business Overview
Table 98. Apotex Inc. Recent Developments
Table 99. Mylan Pharms Inc. Imatinib Drug Basic Information
Table 100. Mylan Pharms Inc. Imatinib Drug Product Overview
Table 101. Mylan Pharms Inc. Imatinib Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Mylan Pharms Inc. Business Overview
Table 103. Mylan Pharms Inc. Recent Developments
Table 104. Global Imatinib Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Imatinib Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Imatinib Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Imatinib Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Imatinib Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Imatinib Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Imatinib Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Imatinib Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Imatinib Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Imatinib Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Imatinib Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Imatinib Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Imatinib Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Imatinib Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Imatinib Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Imatinib Drug Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Imatinib Drug Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Imatinib Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Imatinib Drug Market Size (M USD), 2019-2032
Figure 5. Global Imatinib Drug Market Size (M USD) (2019-2032)
Figure 6. Global Imatinib Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Imatinib Drug Market Size by Country (M USD)
Figure 11. Imatinib Drug Sales Share by Manufacturers in 2023
Figure 12. Global Imatinib Drug Revenue Share by Manufacturers in 2023
Figure 13. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Imatinib Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Imatinib Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Imatinib Drug Market Share by Type
Figure 18. Sales Market Share of Imatinib Drug by Type (2019-2025)
Figure 19. Sales Market Share of Imatinib Drug by Type in 2023
Figure 20. Market Size Share of Imatinib Drug by Type (2019-2025)
Figure 21. Market Size Market Share of Imatinib Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Imatinib Drug Market Share by Application
Figure 24. Global Imatinib Drug Sales Market Share by Application (2019-2025)
Figure 25. Global Imatinib Drug Sales Market Share by Application in 2023
Figure 26. Global Imatinib Drug Market Share by Application (2019-2025)
Figure 27. Global Imatinib Drug Market Share by Application in 2023
Figure 28. Global Imatinib Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global Imatinib Drug Sales Market Share by Region (2019-2025)
Figure 30. North America Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Imatinib Drug Sales Market Share by Country in 2023
Figure 32. U.S. Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Imatinib Drug Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Imatinib Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Imatinib Drug Sales Market Share by Country in 2023
Figure 37. Germany Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Imatinib Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Imatinib Drug Sales Market Share by Region in 2023
Figure 44. China Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Imatinib Drug Sales and Growth Rate (K MT)
Figure 50. South America Imatinib Drug Sales Market Share by Country in 2023
Figure 51. Brazil Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Imatinib Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Imatinib Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Imatinib Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Imatinib Drug Production Market Share by Region (2019-2025)
Figure 62. North America Imatinib Drug Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Imatinib Drug Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Imatinib Drug Production (K MT) Growth Rate (2019-2025)
Figure 65. China Imatinib Drug Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Imatinib Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Imatinib Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Imatinib Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Imatinib Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Imatinib Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Imatinib Drug Market Share Forecast by Application (2025-2032)
